Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis
- 1 July 1979
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 25 (1) , 366-375
- https://doi.org/10.1128/iai.25.1.366-375.1979
Abstract
The importance of intact host defense mechanisms for successful antimicrobial therapy was investigated in an animal model. Recovery from lobar pneumococcal pneumonia as a result of penicillin therapy was studied in normal rats and in rats treated with cobra venom factor. This factor was used to selectively suppress the phagocytosis of pneumococci as a result of complement depletion. Although complete recovery from the infection occurred in normal rats after appropriate penicillin therapy, this was not the case in cobra venom factor-treated rats. Within the limitations of this study, evidence is presented for loss of antibiotic activity as a consequence of impaired phagocytosis.This publication has 41 references indexed in Scilit:
- The Ability of Smooth and Rough Strains of Streptococcus Pneumoniae to Activate Human Complement by the Alternative PathwayJournal of Medical Microbiology, 1978
- Influence of Immunosuppression on the Action of Antimycohacterial Drugs in Experimental TuberculosisChemotherapy, 1976
- Infections in cancer patientsCancer Treatment Reviews, 1975
- Immunocompetence in Advanced Cancer Patients prior to ChemotherapyOncology, 1974
- Changing patterns of infection in cancer patientsPublished by Elsevier ,1973
- Recent experience with bacteremia in patients presenting cancerPublished by Elsevier ,1973
- The effect of a cobra venom factor on complement and adjuvant‐induced disease in ratsArthritis & Rheumatism, 1973
- Study of Bactericidal and Bacteriostatic Antibiotics in Animals with Normal and Suppressed ImmunityChemotherapy, 1968
- AN EXPERIMENTAL ANALYSIS OF THE CURATIVE ACTION OF PENICILLIN IN ACUTE BACTERIAL INFECTIONSThe Journal of Experimental Medicine, 1956
- HOST-PARASITE RELATIONSHIPS IN EXPERIMENTAL PNEUMONIA DUE TO PNEUMOCOCCUS TYPE IIIThe Journal of Experimental Medicine, 1950